Mintzer David M, Zagrabbe Kathryn
Pain and Supportive Care Program, Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, Pennsylvania, USA.
Am J Hosp Palliat Care. 2007 Apr-May;24(2):126-30. doi: 10.1177/1049909106297363.
Delay in referral of cancer patients to hospice until very near the end of life may deny patients and families optimal palliative care. A variety of factors may contribute to these delays. This article describes how the proliferation of newer anticancer therapies, although desirable overall, may further increase these delays. It is important for hospice personnel to understand these changes in medical oncology and to work to optimize palliative care delivery concomitantly with disease-remitting therapies.
将癌症患者转诊至临终关怀机构的时间推迟到生命即将结束时，可能会使患者及其家人无法获得最佳的姑息治疗。多种因素可能导致这些延迟。本文描述了尽管总体上较理想，但更新的抗癌疗法的激增可能会进一步加剧这些延迟。临终关怀人员了解肿瘤医学的这些变化，并努力在进行疾病缓解治疗的同时优化姑息治疗的提供，这一点很重要。
